Papers
1
Total Citations
2
H-Index
1
About
Kai Tao is an emerging researcher at the forefront of oncological imaging and fluorescence-guided surgery, with a particular focus on developing advanced near-infrared (NIR) molecular probes for cancer detection and surgical guidance. His work addresses a critical clinical challenge in prostate cancer treatment: reducing positive surgical margins following radical prostatectomy, which are known to increase the risk of biochemical recurrence and disease progression. By engineering targeted NIR contrast agents with enhanced binding affinity and compatibility with clinical workflows, Tao's research aims to translate fluorescence-guided surgery — already proven beneficial in other cancer types — into effective prostate cancer applications. His 2025 publication on NIR probe engineering, though early in its citation trajectory with 2 citations, reflects a timely and clinically relevant contribution to the rapidly growing field of precision surgical oncology. Tao's interdisciplinary approach, bridging chemistry, molecular biology, and surgical medicine, positions him as a promising contributor to the development of next-generation imaging tools that could meaningfully improve surgical outcomes and patient quality of life in urological oncology.
Research Focus
Key Achievements
Top Papers
- 1